The Effect of Mobilization With Movement on Pain and Function Among Patients With Knee Osteoarthritis
1 other identifier
interventional
38
0 countries
N/A
Brief Summary
Osteoarthritis (OA) is the most prevalent form of arthritis and is reported to be the most important reason behind functional disability and musculoskeletal disorders among aged individuals. OA is "a total joint failure; represented by pathological damage to articular cartilage, that affects bone, menisci, synovium, ligaments, and neuromuscular tissue". Knee OA could be responsible for pain and functional disability in 19.2% of individuals aged more than 45 years in the Framingham study and in 27.8% of such individuals in the Johnston County Osteoarthritis Project. However, in the third National Health and Nutrition Examination Survey (NHANES III), nearly 37% of individuals aged 60 years or older had radiographic knee OA. Oliveria et al. (1995) reported that age- and sex-standardized incidence rates of symptomatic hip, knee, and hand OA were 88, 240, and 100/100,000 person-years, respectively. In addition, the incidence rates of symptomatic OA of the knee, hand, or hip increased rapidly at age 50 and then levelled off beyond age 70. There were not enough data to report the prevalence of OA in Arabic countries. However, a cross-sectional study performed in Saudi Arabia demonstrated radiographic knee OA in 53.3% of men and 60.9% of women, while about 18% of women and 10% of men had symptomatic OA. Although it is well established that OA is mainly caused by damage occurring in the joint because of degeneration and inflammation, there is no known cure for OA and our understanding of the pathological aetiology of OA is still deficient and poorly understood. The primary objective of this study is to investigate the immediate and the carry-over effect of MWM on pain and function in patients with knee OA. A secondary objective is to evaluate this effect among those patients who demonstrate features of central sensitization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 8, 2016
CompletedFirst Posted
Study publicly available on registry
August 12, 2016
CompletedAugust 12, 2016
August 1, 2016
8 months
August 8, 2016
August 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (14)
The Visual Analog Scale (VAS)
Current pain intensity will be measured by a 10-cm line
Change from Baseline in Visual Analog Scale at Immediate post-intervention
The Visual Analog Scale (VAS)
Current pain intensity will be measured by a 10-cm line
Change from Baseline in Visual Analog Scale at 2 days
Western Ontario and McMaster Universities (WOMAC) Index
Self-administered questionnaire presented in Likert-scale format
Change from Baseline in WOMAC at 2 days
Self-Leeds Assessment of Neuropathic Symptoms and signs (S-LANSS) Scale
A clinical-based instrument for identifying patients whose pain is dominated by neuropathic mechanisms
At Baseline
Pressure Pain Threshold (PPT)
A digital pressure algometer will be used to quantify pain intensity in Kpa
Change from Baseline in PPT at Immediate post-intervention
Pressure Pain Threshold (PPT)
A digital pressure algometer will be used to quantify pain intensity in Kpa
Change from Baseline in PPT at 2 days
Thermal Perception and Pain Thresholds
A Thermotest System will be used to determine thermal thresholds in degree centigrade
Change from Baseline in Thermal Perception and Pain Thresholds at Immediate post-intervention
Thermal Perception and Pain Thresholds
A Thermotest System will be used to determine thermal thresholds in degree centigrade
Change from Baseline in Thermal Perception and Pain Thresholds at 2 days
Hand-Held Dynamometer
A digital instrument will be used to examine isometric muscle strength of force development in pound
Change from Baseline in Hand-Held Dynamometer at Immediate post-intervention
Hand-Held Dynamometer
A digital instrument will be used to examine isometric muscle strength of force development for knee flexion and extension in pound
Change from Baseline in Hand-Held Dynamometer at 2 days
Standard Goniometer
Active range of motion for knee flexion and extension in degree
Change from Baseline in Standard Goniometer at Immediate post-intervention
Standard Goniometer
Active range of motion for knee flexion and extension in degree
Change from Baseline in Standard Goniometer at 2 days
Three-meter Timed "Up and Go"
A walk test will be used to test a basic functional mobility
Change from Baseline in Three-meter Timed "Up and Go" at Immediate post-intervention
Three-meter Timed "Up and Go"
A walk test will be used to test a basic functional mobility
Change from Baseline in Three-meter Timed "Up and Go" at 2 days
Study Arms (2)
MWM treatment
ACTIVE COMPARATORMobilization with movement (MWM) is a combination of sustained passive accessory joint mobilization with an active or functional movement. MWM will be applied (three sets of 10 repetitions) during active knee flexion and extension range of motion (ROM). The therapist initially will apply the pain-free manual glide force on the tibia with the knee resting in a mid-range position. The glide force will be sustained while the patient performed 10 repetitions of self-active full range knee flexion and extension; overpressure was included at the end range.
MWM sham
SHAM COMPARATORThe patients will be handled similarly to MWM treatment group, except that they will not receive directional glide; instead, the physiotherapist's hands are just touch the knee skin without pressure; one hand on the tibia while the other hand on the femur. However, available active knee flexion and extension ROM will be performed (three sets of 10 repetitions).
Interventions
Eligibility Criteria
You may qualify if:
- Had unilateral or bilateral knee OA
- Knee OA K\&L grade ≥ 2
- VAS = 3 cm over the previous 24 hours
- Able to walk ≥ 6-meter distances with or without an aid
You may not qualify if:
- Had knee or lower limb surgery
- Oral corticosteroid use (current\\ 4 weeks)
- Altered sensation around knee and shoulder
- Exhibited cognitive difficulties
- Intra-articular corticosteroid or hyaluronic acid injection within 6 months
- Had leg sciatica
- Contraindication to manual therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (11)
Creamer P, Hochberg MC. Osteoarthritis. Lancet. 1997 Aug 16;350(9076):503-8. doi: 10.1016/S0140-6736(97)07226-7. No abstract available.
PMID: 9274595BACKGROUNDKidd BL. Osteoarthritis and joint pain. Pain. 2006 Jul;123(1-2):6-9. doi: 10.1016/j.pain.2006.04.009. Epub 2006 May 22. No abstract available.
PMID: 16714085BACKGROUNDAlghamdi MA, Olney S, Costigan P. Exercise treatment for osteoarthritis disability. Ann Saudi Med. 2004 Sep-Oct;24(5):326-31. doi: 10.5144/0256-4947.2004.326.
PMID: 15573841BACKGROUNDGwilym SE, Pollard TC, Carr AJ. Understanding pain in osteoarthritis. J Bone Joint Surg Br. 2008 Mar;90(3):280-7. doi: 10.1302/0301-620X.90B3.20167.
PMID: 18310746BACKGROUNDGross KD, Hillstrom H. Knee osteoarthritis: primary care using noninvasive devices and biomechanical principles. Med Clin North Am. 2009 Jan;93(1):179-200, xii. doi: 10.1016/j.mcna.2008.09.007.
PMID: 19059028BACKGROUNDFelson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987 Aug;30(8):914-8. doi: 10.1002/art.1780300811.
PMID: 3632732RESULTJordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, Fang F, Schwartz TA, Abbate LM, Callahan LF, Kalsbeek WD, Hochberg MC. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol. 2007 Jan;34(1):172-80.
PMID: 17216685RESULTLawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 Jan;58(1):26-35. doi: 10.1002/art.23176.
PMID: 18163497RESULTOliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995 Aug;38(8):1134-41. doi: 10.1002/art.1780380817.
PMID: 7639811RESULTAl-Arfaj A, Al-Boukai AA. Prevalence of radiographic knee osteoarthritis in Saudi Arabia. Clin Rheumatol. 2002 May;21(2):142-5. doi: 10.1007/s10067-002-8273-8.
PMID: 12086165RESULTAlkhawajah HA, Alshami AM. The effect of mobilization with movement on pain and function in patients with knee osteoarthritis: a randomized double-blind controlled trial. BMC Musculoskelet Disord. 2019 Oct 18;20(1):452. doi: 10.1186/s12891-019-2841-4.
PMID: 31627723DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ali M Alshami, Ph.D
Imam Abdulrahman Bin Faisal University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2016
First Posted
August 12, 2016
Study Start
October 1, 2015
Primary Completion
June 1, 2016
Last Updated
August 12, 2016
Record last verified: 2016-08